Alpha 2.0
Login Register
» Authors » Hideo Matama

Hideo Matama

Explore the profile of Hideo Matama including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 29
Citations 88
Followers 0
Related Specialties
Cardiology & Vascular Diseases
Radiology
General Medicine
Top 10 Co-Authors
Yasuhide Asaumi
Teruo Noguchi
Yu Kataoka
Satoshi Honda
Fumiyuki Otsuka
Masashi Fujino
Shuichi Yoneda
Kota Murai
Takamasa Iwai
Kensuke Takagi
Published In
Cardiovasc Diagn Ther
Atherosclerosis
Int J Cardiovasc Imaging
Am J Cardiol
J Cardiol
Affiliations
Soon will be listed here.
Recent Articles
1.
Surgical repair for postinfarction left ventricular free-wall rupture-25-year single-center experience
Kainuma S, Kawamoto N, Suzuki K, Tadokoro N, Kakuta T, Ikuta A, et al.
Eur J Cardiothorac Surg . 2025 Mar; PMID: 40080710
Objectives: Postinfarction left ventricular free-wall rupture (LVFRW) is a rare, unpredictable, and often fatal complication of acute myocardial infarction. We reviewed our surgical experience with post-infarction LVFWR over 25 years...
2.
Characterization of lipidic plaque features in association with LDL-C<70 mg/dL and lipoprotein(a) <50 mg/dL
Shishikura D, Kataoka Y, Nicholls S, Ray K, Puri R, Kusumoto H, et al.
J Clin Lipidol . 2025 Feb; PMID: 39955203
Background: The ongoing residual cardiovascular risks despite lowering low-density lipoprotein cholesterol (LDL-C) levels suggest the need to identify additional drivers associated with atherosclerosis. Circulating lipoprotein(a) [Lp(a)]promotes formation of foam cells...
3.
Clinical implications of calcification severity adjacent to calcified nodule: Its association with first and recurrent risks of target lesion revascularization after percutaneous coronary intervention
Yabumoto N, Fujino M, Sugane H, Hosoda H, Kitahara S, Fujino Y, et al.
Atherosclerosis . 2025 Feb; 402:119116. PMID: 39903951
Background And Aims: Calcified nodule (CN) is a plaque phenotype characterized by protruding calcification, associated with repeat revascularization after percutaneous coronary intervention (PCI). The severity of calcification increases the risk...
4.
Association between left ventricular reverse remodelling and the B-type natriuretic peptide-cGMP cascade after anterior acute myocardial infarction
Arai M, Asaumi Y, Honda S, Ogata S, Kiyoshige E, Nakao K, et al.
Open Heart . 2025 Jan; 12(1. PMID: 39800436
Background: The role of cyclic guanosine 3',5'-monophosphate (cGMP) after acute myocardial infarction (AMI) is not well understood despite its significance as a second messenger of natriuretic peptides (NPs) in cardiovascular...
5.
Predictive models of in-hospital deterioration of Society of Cardiovascular Angiography and Intervention shock stage in patients with acute myocardial infarction initially presenting with stable hemodynamic condition
Mukaida T, Kataoka Y, Murai K, Sawada K, Iwai T, Matama H, et al.
Cardiovasc Diagn Ther . 2025 Jan; 14(6):1148-1160. PMID: 39790208
Background: The Society of Cardiovascular Angiography and Intervention (SCAI) has defined 5 stages of cardiogenic shock (CS). In patients with acute myocardial infarction (AMI) who initially present in stable hemodynamic...
6.
Change in Pd/Pa: Clinical Implications for Predicting Future Cardiac Events at Deferred Coronary Lesions
Murai K, Kataoka Y, Kiyoshige E, Iwai T, Sawada K, Matama H, et al.
Circ Cardiovasc Interv . 2024 Jul; 17(9):e013830. PMID: 39053911
Background: Cardiovascular events still occur at intermediate stenosis with fractional flow reserve (FFR) ≥0.81, underscoring the additional measure to evaluate this residual risk. A reduction in distal coronary artery pressure/aortic...
7.
Glucagon-like Peptide-1 analogues and delipidation of coronary atheroma in statin-treated type 2 diabetic patients with coronary artery disease: The prespecified sub-analysis of the OPTIMAL randomized clinical trial
Kataoka Y, Kitahara S, Funabashi S, Makino H, Matsubara M, Matsuo M, et al.
Atheroscler Plus . 2024 Apr; 56:1-6. PMID: 38617596
Background And Aims: Randomized clinical trials have demonstrated the ability of glucagon-like peptide-1 analogues (GLP-1RAs) to reduce atherosclerotic cardiovascular disease events in patients with type 2 diabetes (T2D). How GLP-1RAs...
8.
Bypass failure of internal mammary artery caused by subclavian artery stenosis: its clinical characteristics and cardiovascular outcomes in patients receiving coronary artery bypass graft surgery
Tomura N, Kataoka Y, Morris K, Kiyoshige E, Nishimura K, Yagi N, et al.
Cardiovasc Diagn Ther . 2024 Jan; 13(6):956-967. PMID: 38162095
Background: While internal mammary artery (IMA) has become a major conduit of coronary artery bypass graft (CABG) surgery, subclavian artery stenosis (SAS) could cause subsequent coronary events due to ischemia...
9.
The effect of continuous glucose monitoring-guided glycemic control on progression of coronary atherosclerosis in type 2 diabetic patients with coronary artery disease: The OPTIMAL randomized clinical trial
Kataoka Y, Kitahara S, Funabashi S, Makino H, Matsubara M, Matsuo M, et al.
J Diabetes Complications . 2023 Sep; 37(10):108592. PMID: 37741088
Background: Continuous glucose monitoring (CGM) improves glycemic fluctuation and reduces hypoglycemic risk. Whether CGM-guided glycemic control favorably modulates coronary atherosclerosis in patients with type 2 diabetes (T2DM) remains unknown. Methods:...
10.
Effect of Eicosapentaenoic Acid/Docosahexaenoic Acid on Coronary High-Intensity Plaques Detected Using Noncontrast T1-weighted Imaging: The AQUAMARINE EPA/DHA Randomized Study
Nakao K, Noguchi T, Miura H, Asaumi Y, Morita Y, Takeuchi S, et al.
J Atheroscler Thromb . 2023 Sep; 31(2):122-134. PMID: 37704431
Aim: Omega-3 fatty acids have emerged as a new option for controlling the residual risk for coronary artery disease (CAD) in the statin era. Eicosapentaenoic acid (EPA) is associated with...